about
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsControl of viremia in simian immunodeficiency virus infection by CD8+ lymphocytesImmunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesCD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys.Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides.Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatmentElicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysHuman immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramerThe role of Fc receptors in HIV infection and vaccine efficacy.Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric viromeGene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responsesComparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys.Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys.Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.Increased inherent intestinal granzyme B expression may be associated with SIV pathogenesis in Asian non-human primates.Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG VectorsA nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeysKIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NK cell subsets in SIV-infected Mamu-A*01-negative rhesus macaquesOptimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies.Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeysLow frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis.Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsRecombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responsesMagnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman PrimatesDetection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses.Receptors for carbohydrate ligands including heparin on the cell surface of Leishmania and other trypanosomatids.Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys.CD8(+) Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy.CD8+ cell depletion amplifies the acute retroviral syndrome.
P50
Q27318508-F7204C83-751B-477E-860A-2F80E774C88AQ28543248-06E9075A-381A-4AE4-8E32-0C1D8E0206D8Q29616210-76E54CC9-45DB-4E96-AE96-295A57E51D2DQ33355730-D4916B9D-637E-4797-9BA3-899FD036943CQ33618007-ECE3EB45-95C3-4B7E-954D-66BDEB61C22DQ33642024-73B66D3A-F91B-43F4-BF64-1D501C5D209CQ33806000-BAAFB8EE-6299-40E2-B915-6628D6241F42Q33822282-C5648DC1-D062-422C-9F32-A88B66207FE9Q33847673-8FE80F40-1892-437E-981A-0F5C47F3066AQ33850904-16E29B01-5A7C-4188-B0BF-8C54FA381DFAQ33874534-6365EC58-2AD7-44DB-88C6-C74C17C4C8D6Q33997395-FCACA963-4150-4C1A-A11D-2143F556930CQ34305895-4EBD3996-2F41-4E05-A479-71965A239CB9Q34595741-01DC7AD8-D4D8-4C65-A152-67C9812DBB3DQ34647722-90E33522-FD39-4385-AC5F-0845E5F08C2AQ34781957-0832305F-BA02-4846-9DE2-DC2A14A90724Q35185901-0C69915B-BF3D-4889-9EC7-79846731E6D0Q35192646-611D1BB9-7B6B-4C64-AE5A-2CA9C291E518Q35353641-306B5137-D4FD-49F0-8F7C-A6CEA37FD937Q35530297-DB02FA3B-349D-482B-AD8F-5D43BE293C21Q35773904-D92E0D6E-71AC-4CC7-9652-4D748312CD19Q35787109-6C84A53F-3664-4C1C-A5AC-7356F7BBED93Q35861276-AB23FEBB-A2BC-4B56-9326-51AD4F0AD5C9Q35913945-3893CBCD-6A4D-44D6-8FA3-8655760D513DQ36673275-2999FC58-4DB9-49DD-9B73-C20593CBB283Q36759934-1B0355DF-E1F6-47F2-8D44-77E0B7049FADQ36822332-BC732D6C-9F54-49F5-A301-5540A80A1C3EQ36845836-F09B757B-0252-4D90-8CDA-07E25FB043FCQ36890313-AA55D676-2286-4642-8590-675C5D42A37BQ36974698-1D7BBD0D-E277-4CE0-B7C9-D23B15C66E41Q37273233-225CD9F3-01F9-482A-A4D5-48B3BCA122D9Q37273652-FD57203D-39BD-4C7B-9085-F1670B89C410Q37285535-6FA1B34E-08C5-4906-9EEC-974175F3E6A1Q37409258-A2913063-1CB8-408C-A183-0C4B83B6D4CEQ37492573-E363CC74-79BB-4398-A608-FAC546158D91Q37497214-51E3171F-F420-4F34-882C-ADDBF063C617Q39143002-2DD654DD-6BB3-4B83-AA9E-989C984C8089Q39996538-1143453F-7705-4D1D-A634-DB72763EFA06Q40532397-139E3D50-9D16-4509-9ED2-D105510C09C6Q40539640-F17E5783-4A2B-4E99-9420-9A41F14069D3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joern E Schmitz
@ast
Joern E Schmitz
@en
Joern E Schmitz
@es
Joern E Schmitz
@nl
Joern E Schmitz
@sl
type
label
Joern E Schmitz
@ast
Joern E Schmitz
@en
Joern E Schmitz
@es
Joern E Schmitz
@nl
Joern E Schmitz
@sl
prefLabel
Joern E Schmitz
@ast
Joern E Schmitz
@en
Joern E Schmitz
@es
Joern E Schmitz
@nl
Joern E Schmitz
@sl
P106
P31
P496
0000-0001-8803-0922